Travere Therapeutics CEO Eric M. Dube Reports Sale of $13.12 Million in Common Shares

Bitget2026/10/19 20:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Travere Therapeutics CEO Eric M. Dube sold 243,735 common shares on October 15, 2026.
Sales comprised 128,065 shares at $52.9672, 37,270 at $54.1997, and 78,400 at $55.0179.
Dube exercised employee stock options for 43,735 common shares at $26.88 per share.
A separate exercise covered 200,000 common shares at $8.93 per share.
His direct common stock holdings stood at 432,886 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001763494-26-000008), on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Travere Therapeutics CEO Eric M. Dube Reports Sale of $13.12 Million in Common Shares

You may also like

Crypto prices